Literature DB >> 5898679

[On the pharmacokinetics of 1-butyl-biguanide hydrochloride and the prolonged-action form of this substance].

R Beckmann, G Hübner.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1965        PMID: 5898679

Source DB:  PubMed          Journal:  Arzneimittelforschung        ISSN: 0004-4172


× No keyword cloud information.
  6 in total

1.  Butylbiguanide concentration in plasma, liver, and intestine after intravenous and oral administration to man.

Authors:  W Lintz; W Berger; W Aenishaenslin; V Kutova; C Baerlocher; J P Kapp; R Beckmann
Journal:  Eur J Clin Pharmacol       Date:  1974-10-04       Impact factor: 2.953

2.  [Absorption, distribution in the organism and elimination of metformin].

Authors:  R Beckmann
Journal:  Diabetologia       Date:  1969-10       Impact factor: 10.122

3.  [Changes in glucose tolerance and insulin level in healthy persons following administration of N1-butyl-biguanide retard].

Authors:  F Gomez; V Büber; J P Felber
Journal:  Klin Wochenschr       Date:  1969-12-15

4.  [Experimental studies on the method of action of Buformin].

Authors:  P Petrides; P Schräpler
Journal:  Klin Wochenschr       Date:  1966-10-15

Review 5.  The Mechanism of Action of Biguanides: New Answers to a Complex Question.

Authors:  Laura Di Magno; Fiorella Di Pastena; Rosa Bordone; Sonia Coni; Gianluca Canettieri
Journal:  Cancers (Basel)       Date:  2022-06-30       Impact factor: 6.575

6.  Evaluation of a sustained release form of the oral antidiabetic butylbiguanide (Silubin retard).

Authors:  R Beckmann; W Lintz; E Schmidt-Böthelt
Journal:  Eur J Clin Pharmacol       Date:  1971-09       Impact factor: 2.953

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.